Norton Waterford Drug Patent Portfolio
Norton Waterford owns 1 orange book drug protected by 18 US patents Given below is the list of Norton Waterford's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11583643 | Inhalers and related methods | 19 Aug, 2041 | Active |
| US11957832 | Breath actuated inhaler | 05 May, 2041 | Active |
| US11559637 | Inhalers and related methods | 21 Jul, 2039 | Active |
| US10792447 | Breath actuated inhaler | 25 Jan, 2039 | Active |
| US11395888 | Inhalers and related methods | 26 Jan, 2038 | Active |
| US11793953 | Inhalers and related methods | 26 Jan, 2038 | Active |
| US11865247 | Inhalers and related methods | 26 Jan, 2038 | Active |
| US11896759 | Inhalers and related methods | 26 Jan, 2038 | Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | 01 Jan, 2032 | Active |
| US8931476 | Inhaler | 17 Jul, 2031 | Active |
| US10022509 | Dose counter for inhaler having a bore and shaft arrangement | 18 May, 2031 | Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | 18 May, 2031 | Active |
| US10086156 | Dose counter for inhaler and method for counting doses | 18 May, 2031 | Active |
| US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator | 18 May, 2031 | Active |
| US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator | 18 May, 2031 | Active |
| US8132712 | Metered-dose inhaler | 07 Sep, 2028 | Active |
| US7637260 | Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber | 25 Aug, 2020 | Expired |
| US6446627 | Inhaler dose counter | 18 Dec, 2017 | Expired |
Latest Legal Activities on Norton Waterford's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Norton Waterford.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Mar, 2024 | US10792447 |
|
Recordation of Patent Grant Mailed
Critical
| 13 Feb, 2024 | US11896759 |
| Recordation of Patent eGrant | 13 Feb, 2024 | US11896759 |
| Mail Patent eGrant Notification | 13 Feb, 2024 | US11896759 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 13 Feb, 2024 | US11896759 |
| Patent eGrant Notification | 13 Feb, 2024 | US11896759 |
|
Email Notification
Critical
| 13 Feb, 2024 | US11896759 |
|
Email Notification
Critical
| 25 Jan, 2024 | US11896759 |
|
Issue Notification Mailed
Critical
| 24 Jan, 2024 | US11896759 |
| Dispatch to FDC | 16 Jan, 2024 | US11896759 |
|
Application Is Considered Ready for Issue
Critical
| 16 Jan, 2024 | US11896759 |
| Mail Patent eGrant Notification | 09 Jan, 2024 | US11865247 |
| Recordation of Patent eGrant | 09 Jan, 2024 | US11865247 |
| Patent eGrant Notification | 09 Jan, 2024 | US11865247 |
|
Email Notification
Critical
| 09 Jan, 2024 | US11865247 |
Norton Waterford's Drug Patent Litigations
Norton Waterford's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Oct 26, 2018, against patent number US10561808. The petitioner , challenged the validity of this patent, with Declan Walsh et al. as the respondent. Click below to track the latest information on how companies are challenging Norton Waterford's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US10561808 | October, 2018 |
Decision
(20 Sep, 2019)
| Declan Walsh et al. | |
Norton Waterford's Family Patents
Norton Waterford Drug List
Given below is the complete list of Norton Waterford's drugs and the patents protecting them.
1. Qvar Redihaler
Qvar Redihaler is protected by 18 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11583643 | Inhalers and related methods |
19 Aug, 2041
(16 years from now)
| Active |
| US11957832 | Breath actuated inhaler |
05 May, 2041
(16 years from now)
| Active |
| US11559637 | Inhalers and related methods |
21 Jul, 2039
(14 years from now)
| Active |
| US10792447 | Breath actuated inhaler |
25 Jan, 2039
(14 years from now)
| Active |
| US11395888 | Inhalers and related methods |
26 Jan, 2038
(13 years from now)
| Active |
| US11793953 | Inhalers and related methods |
26 Jan, 2038
(13 years from now)
| Active |
| US11865247 | Inhalers and related methods |
26 Jan, 2038
(13 years from now)
| Active |
| US11896759 | Inhalers and related methods |
26 Jan, 2038
(13 years from now)
| Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(7 years from now)
| Active |
| US8931476 | Inhaler |
17 Jul, 2031
(6 years from now)
| Active |
| US10022509 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(6 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(6 years from now)
| Active |
| US10086156 | Dose counter for inhaler and method for counting doses |
18 May, 2031
(6 years from now)
| Active |
| US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(6 years from now)
| Active |
| US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(6 years from now)
| Active |
| US8132712 | Metered-dose inhaler |
07 Sep, 2028
(3 years from now)
| Active |
| US7637260 | Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber |
25 Aug, 2020
(4 years ago)
| Expired |
| US6446627 | Inhaler dose counter |
18 Dec, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qvar Redihaler's drug page